Sentinel node biopsy in breast cancer

Annals of Surgical Oncology

Volumn 5, Issue 2, 1998, Pages 126-130

  Barnwell, John M ^a   Arredondo, Mark A ^a   Kollmorgen, Daniel ^a   Gibbs, John F ^a   Lamonica, Dominick ^a   Carson, William ^a   Zhang, Paul ^a   Winston, Janet ^a   Edge, Stephen B ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Axillary lymph node dissection; Breast neoplasms; Lymphatic mapping; Prognosis; Staging

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST NEOPLASMS; FEMALE; GAMMA CAMERAS; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHATIC SYSTEM; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MONITORING, INTRAOPERATIVE; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; ROSANILINE DYES; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 0032417820     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02303845     Document Type: Article

References (25)

1. Treatment of early-stage breast cancer. NIH Consensus Statement 1990 June 18-21;8(6):1-19.
2. Bland KI. Enhancing the accuracy for predictors of axillary nodal metastasis in T1 carcinoma of the breast: role of selective biopsy with lymphatic mapping [editorial]. J Am Coll Surg 1996;183: 262-4.
3. Baxter N, McCready D, Chapman JA, et al. Clinical behavior of untreated axillary nodes after local treatment for primary breast cancer. Ann Surg Oncol 1996;3:235-40.
4. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312: 674-81.
5. Recht A, Houlihan MJ. Axillary lymph nodes and breast cancer: a review. Cancer 1995;76:1491-1512.
6. Morrow M. Role of axillary dissection in breast cancer management [editorial]. Ann Surg Oncol 1996;3:233-4.
7. Giuliano AE, Barth AM, Spivack B, Bietsch PD, Evans SW. Incidence and predictors of axillary metastases in T1 carcinoma of the breast. J Am Coll Surg 1996;183:185-9.
8. Choong PL, deSilva CJS, Dawkins HJS, et al. Predicting axillary lymph node metastases in breast carcinoma patients. Breast Cancer Res Treat 1996;37:135-49.
9. Ravdin PM, De Laurentiis M, Vendely T, Clark GM. Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst 1994;86:1771-5.
10. Noguchi M, Katev N, Miyazaki I. Diagnosis of axillary lymph node metastases in patients with breast cancer. Breast Cancer Res Treat 1996;40:283-93.
11. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
12. Krag DN, Meijer SJ, Weaver DL. et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995;130:654-8.
13. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-9.
14. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-8.
15. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy [Review]. Ann Surg 1995;222:394-9.
16. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276:1818-22.
17. Statman RC, Jones RC, Cabot MC, Giuliano AE. Sentinel lymphadenectomy: a technique to eliminate axillary dissection in node-negative breast cancer [Abstract]. Proc Am Soc Clin Oncol 1996; 15:125.
18. Uren RF, Howman-Giles RB, Thompson JF, et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995;36:1775-80.
19. Wahl RL, Liebert M, Wilson BS, Petry NA. Radiolabeled antibodies, albumin and antimony sulfide colloid: a comparison as lymphoscintigraphic agents. Int J Rad Appl Instrum [B] 1988;15: 243-50.
20. Nathanson SD, Anaya P, Karvelis KC, Eck L, Havstad S. Sentinel lymph node uptake of two different technetium-labeled radiocolloids. Ann Surg Oncol 1997;4:104-10.
21. Trojani M, de Mascarel I, Bonichon F, Delson G. Micrometastases to axillary lymph nodes from carcinoma of the breast: Detection by immunohistochemistry and prognostic significance. Br J Cancer 1987;55:303-6.
22. Noguchi S, Aihara T, Motomura K, Inaji H, Imaoka S, Koyama H. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction: Comparison between MUC1 mRNA and Keratin 19 mRNA amplification. Am J Pathol 1996;148:649-56.
23. McGuckin MA, Cummings MC, Walsh MD, Hohn BG, Bennett IC, Wright RG. Occult axillary node metastases in breast cancer their detection and prognostic significance. Br J Cancer 1996;73 88-95.
24. Hainsworth PJ, Tjandra JJ, Stillwell RG, et al. Detection and significance of occult metastases in node-negative breast cancer. Br J Surg 1993;80:459-63.
25. Giuliano AE. Lymphatic mapping and sentinel node biopsy in breast cancer (letter). JAMA 1997;277:791.